Model‐Informed Dose Optimization of Anakinra in Preterm Neonates Implications for Safe and Effective Dosing
The developed population PK model for anakinra delivers the first critical understanding of small protein PK in premature neonates, establishing a foundation for evidence‐based dosing strategies to guide future prospective clinical trials.